Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Pharmaids Pharmaceuticals Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹29.68 |
|---|---|
| Day's Range | ₹29.15 - ₹30.78 |
| Open | ₹29.71 |
| 52 Week Range | ₹25.60 - ₹66.00 |
| Volume | 4,555 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1.36 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -1.29 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 2.11 |
| PAT Margin (%) | -41.50 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -15.67 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 11.15 | 23.41 |
| Expenses | N/A | N/A |
| PBT | -56.92 | -85.87 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -43.63 | -72.79 |
About Pharmaids Pharmaceuticals Ltd.
| Founded | 1989 |
|---|
Latest News
Pharmaids Pharmaceuticals informs about newspaper advertisement
Pursuant to Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that it enclosed copies of the newspaper advertisement pertaining to the unaudited financial results of the company for the quarter ended June 30, 2026. The advertisement was published on Friday, August 14, 2026, in English Newspaper having nationwide circulation 'Financial Express' and Vernacular Newspaper 'Hosa Digantha'. This information will also be made available on the Company’s website at: www.pharmaids.com.
The above information is a part of company’s filings submitted to BSE.
Pharmaids Pharmaceuticals informs about outcome of board meeting
Pursuant Regulation 30 read with Schedule III of Listing Regulations, Pharmaids Pharmaceuticals has informed that the Board of Directors of the Company at their meeting held on Tuesday, June 30, 2026, have, basis recommendation of the Audit Committee, considered and approved the appointment of V Mahendra & Associates Chartered Accountants (FRN: 025356S) as Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular dated January 30, 2026, is enclosed as Annexure A. The above Information is being made available on the Company’s website: www.pharmaids.com.
The above information is a part of company’s filings submitted to BSE.
Centenial Surgical Suture informs about trading window closure
Bharat Parenterals informs about proceedings of AGM
Family Care Hospitals informs about corrigendum to annual report
In continuation of intimation dated September 5, 2026, regarding Notice of the 32nd Annual General Meeting and the Annual Report (AR) for FY 2025-26 of the Family Care Hospital, Family Care Hospitals has informed that a revised version of the Annual Report has been uploaded to the Company’s website. The company has informed that the revision in the AR are only relating to the correction of certain minor typographical / formatting issues and that there are no substantive changes being undertaken to the contents of the AR. The Notice of the 32nd Annual general Meeting and the Annual Report are also being uploaded on the website of the Company at www.familycarehospitals.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Pharmaids Pharmaceuticals Ltd. is ₹29.68 as of 2026-09-18.
The market capitalisation of Pharmaids Pharmaceuticals Ltd. is ₹104.67 as of 2026-09-18.
The 1-year return of Pharmaids Pharmaceuticals Ltd. is -27.17% as of 2026-09-18.
The P/E ratio of Pharmaids Pharmaceuticals Ltd. is 0.00 as of 2026-09-20.
The 52-week high and low of Pharmaids Pharmaceuticals Ltd. are ₹66.00 and ₹25.60, respectively, as of 2026-09-18.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
